Cancer patients overwhelmingly prefer quick shot over lengthy IV drip
NCT ID NCT05171777
Summary
This study aimed to find out if patients and healthcare staff prefer a new under-the-skin injection for a lung cancer drug over the standard intravenous (IV) infusion. 179 adults with non-small cell lung cancer tried both methods. The main goal was to measure which way of getting the medicine people liked better and why, focusing on convenience and satisfaction.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
A.O.U. Maggiore della Carità
Novara, Piedmont, 28100, Italy
-
Asan Medical Center
Seoul, 05505, South Korea
-
Asante Rogue Regional Medical Center
Medford, Oregon, 97504-8332, United States
-
Azienda Ospedaliera Universitaria Senese
Siena, Abruzzo, 53100, Italy
-
CEMIC
Buenos Aires, C1431FWN, Argentina
-
Centro Oncologico Korben
Ciudad Autonoma Buenos Aires, C1426AGE, Argentina
-
Chungbuk National University Hospital
Cheongju-si, 28644, South Korea
-
Clinica CIMCA
San José, 10103, Costa Rica
-
Complejo Hospitalario Universitario A Coruña (CHUAC)
A Coruña, LA Coruna, 15006, Spain
-
Fundación CENIT para la Investigación en Neurociencias
Buenos Aires, C1125ABD, Argentina
-
Hospital Clinico Universitario Lozano Blesa
Zaragoza, 50009, Spain
-
Hospital Nossa Senhora da Conceicao
Porto Alegre, Rio Grande do Sul, 91350-200, Brazil
-
Hospital Universitari Vall d'Hebron
Barcelona, 08035, Spain
-
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
-
Hospital Universitario de Canarias
San Cristóbal de La Laguna, Tenerife, 38320, Spain
-
Hospital das Clinicas - UFRGS
Porto Alegre, Rio Grande do Sul, 90035-903, Brazil
-
Hospital de la Santa Creu i Sant Pau
Barcelona, 08041, Spain
-
ICIMED Instituto de Investigación en Ciencias Médicas
San José, 10108, Costa Rica
-
IRCCS Istituto Regina Elena (IFO)
Rome, Lazio, 00144, Italy
-
Instituto Europeo di Oncologia
Milan, Lombardy, 20141, Italy
-
Instituto do Cancer do Estado de Sao Paulo - ICESP
São Paulo, São Paulo, 01246-000, Brazil
-
Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy
Otwock, 05-400, Poland
-
New Jersey Hematology Oncology Associates LLC
Brick, New Jersey, 08724-3009, United States
-
Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda
Ijuí, Rio Grande do Sul, 98700-000, Brazil
-
OrlandiOncología
Santiago, 7500713, Chile
-
Oulun yliopistollinen sairaala (OYS)
Oulu, 90220, Finland
-
Pauls Stradins Clinical University Hospital
R?ga, LV-1002, Latvia
-
Riga East Clinical University Hospital Latvian Oncology Centre
Riga, LV-1079, Latvia
-
Royal Victoria Regional Health Centre
Barrie, Ontario, L4M 6M2, Canada
-
Sault Area Hospital
Sault Ste. Marie, Ontario, P6B 0A8, Canada
-
Tampereen yliopistollinen sairaala (TAYS)
Tampere, 33521, Finland
-
Tri County Hematologyoncology
Massillon, Ohio, 44646-9128, United States
-
Turun yliopistollinen keskussairaala (TYKS)
Turku, 20521, Finland
-
UPMC - Hillman Cancer Center
Pittsburgh, Pennsylvania, 15232, United States
-
Vaasan Keskussairaala
Vaasa, 65130, Finland
-
Warminsko-Mazurskie Centrum Chorób P?uc w Olsztynie
Olsztyn, 10-357, Poland
Conditions
Explore the condition pages connected to this study.